A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C
Abstract
An SVR reduced mortality among patients infected with HCV of genotypes 1, 2, or 3 who were being treated by routine medical practice and had substantial comorbidities.
Keywords
hepatitis c
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
u.s. gov't
non-p.h.s.
female
male
middle aged
United States
Survival Analysis
ribavirin / administration & dosage
viral load*
chronic / mortality*
antiviral agents / administration & dosage*
chronic / drug therapy
chronic / virology*
pmid:21397729
doi:10.1016/j.cgh.2011.03.004
lisa i backus
derek b boothroyd
larry a mole
hepacivirus / isolation & purification*
interferons / administration & dosage
Access
Citation
ID:
269612
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
269612
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet